Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Mao Uematsu"'
Autor:
Kaede Baba, Megumi Kawamoto, Kanako Mamishin, Mao Uematsu, Hikari Kiyohara, Akira Hirota, Nobuyuki Takahashi, Misao Fukuda, Shota Kusuhara, Hiromichi Nakajima, Chikako Funasaka, Takehiro Nakao, Chihiro Kondoh, Kenichi Harano, Nobuaki Matsubara, Yoichi Naito, Ako Hosono, Toshikatsu Kawasaki, Toru Mukohara
Publikováno v:
Cancer Medicine, Vol 12, Iss 11, Pp 12095-12105 (2023)
Abstract Background Since it was first reported in December 2019, coronavirus disease 2019 (COVID‐19) spread rapidly across the globe resulting in a pandemic. As of August 2022, seven outbreak peaks have been confirmed in Tokyo, and the numbers of
Externí odkaz:
https://doaj.org/article/c0255b117bae403e9d5e854df13ba152
Autor:
Mao Uematsu, Yusuke Kanemasa, Shohei Nakamura, Chikako Funasaka, Akihiko Kageyama, Tatsu Shimoyama, Yasushi Omuro
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 3, Pp 928-934 (2019)
Choriocarcinoma is a highly aggressive germ cell tumor and can metastasize to the brain. Although brain metastasis has a poor prognosis, the optimal treatment strategy remains unclear due to its low incidence. A 33-year-old man presenting with multip
Externí odkaz:
https://doaj.org/article/86f8cb3e5b6743588f4195fdb61abfac
Autor:
Mao Uematsu, MD, Tomonari Kinoshita, MD, PhD, Naomichi Sasaki, MD, Yusuke Sugita, MD, Reiko Shimizu, MD, Toshiyuki Shima, MD, Masahiko Harada, MD, PhD, Makiko Yomota, MD, PhD, Tsunekazu Hishima, MD, PhD, Hirotoshi Horio, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 1, Iss 3, Pp 100040- (2020)
Externí odkaz:
https://doaj.org/article/62db0663017347668cb557f6f823ad55
Autor:
Mao Uematsu, Hiromichi Nakajima, Ako Hosono, Hikari Kiyohara, Akira Hirota, Nobuyuki Takahashi, Misao Fukuda, Shota Kusuhara, Takehiro Nakao, Chikako Funasaka, Chihiro Kondoh, Kenichi Harano, Nobuaki Matsubara, Yoichi Naito, Tetsuo Akimoto, Toru Mukohara
Publikováno v:
Melanoma Research; Dec2023, Vol. 33 Issue 6, p547-552, 6p
Publikováno v:
Journal of Oleo Science; 2023, Vol. 72 Issue 11, p1049-1054, 6p
Autor:
Kaede Baba, Megumi Kawamoto, Kanako Mamishin, Mao Uematsu, Hikari Kiyohara, Akira Hirota, Nobuyuki Takahashi, Misao Fukuda, Shota Kusuhara, Hiromichi Nakajima, Chikako Funasaka, Takehiro Nakao, Chihiro Kondoh, Kenichi Harano, Nobuaki Matsubara, Yoichi Naito, Ako Hosono, Toshikatsu Kawasaki, Toru Mukohara
Publikováno v:
Cancer Medicine.
Autor:
Naomichi Sasaki, Masahiko Harada, Hirotoshi Horio, Tomonari Kinoshita, Reiko Shimizu, Toshiyuki Shima, Tsunekazu Hishima, Aya Yamamoto, Yusuke Sugita, Mao Uematsu
Publikováno v:
J Thorac Dis
Background Limited lung resection is generally believed to be available for lung adenocarcinoma in situ (AIS). At our institute, intraoperative hematoxylin-eosin staining of frozen-section slides is routinely performed for evaluating tumor invasivene
Autor:
Tatsu Shimoyama, Shohei Nakamura, Mao Uematsu, Chikako Funasaka, Yasushi Omuro, Yusuke Kanemasa, Akihiko Kageyama
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 3, Pp 928-934 (2019)
Case Reports in Oncology
Case Reports in Oncology
Choriocarcinoma is a highly aggressive germ cell tumor and can metastasize to the brain. Although brain metastasis has a poor prognosis, the optimal treatment strategy remains unclear due to its low incidence. A 33-year-old man presenting with multip
For cancer immunotherapy, the tumor proportion score for the programmed death-1 ligand is not a robust biomarker. The peripheral blood eosinophil count (PEC) is a potential alternative. However, it is not yet established. To test the efficacy of PEC-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4dc90172825c4de14dd41cd857cdf393
https://doi.org/10.21203/rs.3.rs-967835/v1
https://doi.org/10.21203/rs.3.rs-967835/v1
Autor:
Naomichi Sasaki, Tomonari Kinoshita, Toshiyuki Shima, Tsunekazu Hishima, Hirotoshi Horio, Yusuke Sugita, Mao Uematsu, Reiko Shimizu, Masahiko Harada
Publikováno v:
General thoracic and cardiovascular surgery. 69(7)
Lymphatic permeation (LY) and vascular invasion (VI) are well-known as postoperative prognostic factors in non-small cell lung cancer (NSCLC). Some reports use the term “lymphovascular invasion (LVI)” in reference to the integration of LY and VI.